MaxCyte Inc.’s filing revealed that its Director Johnston John Joseph unloaded Company’s shares for reported $10512.0 on Aug 30. In the deal valued at $3.70 per share,2,841 shares were sold. As a result of this transaction, Johnston John Joseph now holds 120,583 shares worth roughly $ 0.44 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Johnston John Joseph sold 2,059 shares, generating $7,618 in total proceeds. Upon selling the shares at $3.70, the Director now owns 120,583 shares.
Before that, Johnston John Joseph sold 100 shares. MaxCyte Inc. shares valued at $370 were divested by the Director at a price of $3.70 per share. As a result of the transaction, Johnston John Joseph now holds 120,583 shares, worth roughly $0.44 million.
Price Performance Review of MXCT
On Tuesday, MaxCyte Inc. [NASDAQ:MXCT] saw its stock fall -1.35% to $3.65. On the same session, the stock had its day’s lowest price of $3.56, but rose to a high of $3.73. Over the last five days, the stock has gained 3.40%. MaxCyte Inc. shares have fallen nearly -33.15% since the year began. Nevertheless, the stocks have fallen -33.03% over the past one year. While a 52-week high of $7.50 was reached on 01/31/23, a 52-week low of $3.45 was recorded on 08/25/23. SMA at 50 days reached $4.30, while 200 days put it at $4.79. A total of 0.67 million shares were traded, compared to the trading of 0.3 million shares in the previous session.
Levels Of Support And Resistance For MXCT Stock
The 24-hour chart illustrates a support level at 3.56, which if violated will result in even more drops to 3.48. On the upside, there is a resistance level at 3.73. A further resistance level may holdings at 3.82. The Relative Strength Index (RSI) on the 14-day chart is 38.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.00, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 50.00%. Stochastics %K at 54.12% indicates the stock is a holding.
How much short interest is there in MaxCyte Inc.?
A steep rise in short interest was recorded in MaxCyte Inc. stocks on Aug 14, 2023, growing by 60000.0 shares to a total of 1.93 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 1.87 million shares. There was a rise of 3.11%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.89% of the overall stock float, the days-to-cover ratio (short ratio) rose to 5.88.